ARTICLE | Clinical News
Hematide: Phase III ongoing
August 11, 2008 7:00 AM UTC
An independent DMC recommended the continuation of the open-label, international Phase III EMERALD 2 trial based on a review of safety data from all 4 studies involved in the Phase III program. The 52...